Literature DB >> 22467843

A patient with bipolar disorder and antiphospholipid syndrome.

Jimmy N Avari1, Robert C Young.   

Abstract

Antiphospholipidsyndrome (APS) is an autoimmune disorder which causes a hyper-coagulable state characterized by recurrent thrombosis. It has a diverse range of central nervous system manifestations. We describe a case of a 61 year old man with bipolar disorder and APS, and we compare this to a previously reported case. Additionally, we reviewed literature regarding APS-related markers and the relationship of APS to other psychiatric and neurologic illnesses. We discuss possible mechanisms for an association between APS and bipolar disorder. We encourage clinicians to be aware of this possible relationship and have proposed research strategies.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22467843      PMCID： PMC3694414          DOI： 10.1177/0891988712436691

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN： 0891-9887            Impact factor:   2.680


  16 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

2.  IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

Authors:  S R Levine; L Salowich-Palm; K L Sawaya; M Perry; H J Spencer; H J Winkler; Z Alam; J L Carey
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

3.  Dementia and antiphospholipid antibodies.

Authors:  A Mosek; I Yust; T A Treves; N Vardinon; A D Korczyn; J Chapman
Journal:  Dement Geriatr Cogn Disord       Date:  2000 Jan-Feb       Impact factor: 2.959

4.  Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.

Authors:  J Chapman; M Cohen-Armon; Y Shoenfeld; A D Korczyn
Journal:  Lupus       Date:  1999       Impact factor: 2.911

Review 5.  The nature and management of mania in old age.

Authors:  K I Shulman; N Herrmann
Journal:  Psychiatr Clin North Am       Date:  1999-09

6.  High association of anticardiolipin antibodies with psychosis.

Authors:  M Schwartz; M Rochas; B Weller; A Sheinkman; I Tal; D Golan; N Toubi; I Eldar; B Sharf; D Attias
Journal:  J Clin Psychiatry       Date:  1998-01       Impact factor: 4.384

7.  Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.

Authors:  M L Bertolaccini; B Roch; O Amengual; T Atsumi; M A Khamashta; G R Hughes
Journal:  Br J Rheumatol       Date:  1998-11

8.  Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.

Authors:  Michael Maes; Ivanka Mihaylova; Jean-Claude Leunis
Journal:  Neuro Endocrinol Lett       Date:  2007-12       Impact factor: 0.765

9.  Mania: psychiatric manifestations of the antiphospholipid syndrome.

Authors:  Haniya Raza; Steven A Epstein; Maryland Pao; Donald L Rosenstein
Journal:  Psychosomatics       Date:  2008 Sep-Oct       Impact factor: 2.386

10.  Partial seizures associated with antiphospholipid antibodies in childhood.

Authors:  L Angelini; T Granata; F Zibordi; S Binelli; G Zorzi; C Besana
Journal:  Neuropediatrics       Date:  1998-10       Impact factor: 1.947
View more
  1 in total

Review 1.  Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.

Authors:  Cécile M Yelnik; Elizabeth Kozora; Simone Appenzeller
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.